(Philadelphia, PA) - Robert G. Kalb, MD, has been named Associate Professor in the Department of Neurology at the University of Pennsylvania School of Medicine.

Dr. Kalb earned his BA degree in Biology from Wesleyan University and his MD from Cornell University Medical College. He performed his internship and residency in Medicine at Montefiore Hospital in the Bronx, New York. He completed a second residency, in Neurology, at Yale-New Haven Hospital in Connecticut and a fellowship in the Department of Neurobiology at Yale University.
Dr. Kalb's laboratory studies the molecular mechanisms by which precise connections form between neurons during development. His lab also studies why motor neurons are vulnerable to insult, in relation to Lou Gehrig's Disease.

He is a member of the American Association for the Advancement of Science, the American Neurologic Association, the Society for Neuroscience, and the American Academy of Neurology. Among his many accolades, Dr. Kalb has received the 2001 National Aeronautics and Space Administration (NASA) Group Achievement Award from the Neurolab Spacelab Mission Science Team, and the 2002 Decade of Service Award-Teaching and Guidance, from Yale University.

Dr. Kalb is an ad-hoc reviewer for Neuron, Journal of Neuroscience, Proceedings of the National Academy of Science, European Journal of Neuroscience, Experimental Brain Research, Brain Research and the Journal of Neurobiology, among others. He has been invited to lecture on several occasions, most recently at Yale University on the topic, "The role of trophic factors in excitotoxic motor neuron death." He has authored or co-authored research in peer and non-peer reviewed publications including Neuroscience, Neuron, the Journal of Neuroscience, Annals of Neurology, Nature, the Journal of Neurochemistry and Annals of the New York Academy of Science.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.

Share This Page: